# Circulating Tumor DNA in Surgical Lung Cancer Patients

> **NCT03081741** · — · UNKNOWN · sponsor: **Shenzhen Gene Health Bio Tech Co., Ltd.** · enrollment: 500 (estimated)

## Conditions studied

- Lung Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03081741
- **Lead sponsor:** Shenzhen Gene Health Bio Tech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-03
- **Primary completion:** 2017-12-01
- **Final completion:** 2020-03-18
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2017-05-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03081741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03081741, "Circulating Tumor DNA in Surgical Lung Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03081741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*